Given that elevated PKC signaling has been detected as one of the earliest events in the pathology of AD29, we asked whether the steady-state levels of PKCα might be elevated in AD, resulting in enhanced signaling output. The gene discussed is PRRT2; the disease is Alzheimer disease.